School of Electrical and Mechanical Engineering, University of Adelaide, Adelaide, SA 5005, Australia.
Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Adelaide, SA 5005, Australia.
Biosensors (Basel). 2023 Feb 24;13(3):319. doi: 10.3390/bios13030319.
Atherosclerosis is a leading cause of morbidity and mortality, and high-risk atherosclerotic plaques can result in myocardial infarction, stroke, and/or sudden death. Various imaging and sensing techniques (e.g., ultrasound, optical coherence tomography, fluorescence, photoacoustic) have been developed for scanning inside blood vessels to provide accurate detection of high-risk atherosclerotic plaques. Nanoparticles have been utilized in intravascular imaging to enable targeted detection of high-risk plaques, to enhance image contrast, and in some applications to also provide therapeutic functions of atherosclerosis. In this paper, we review the recent progress on developing nanoparticles for intravascular imaging of atherosclerosis. We discuss the basic nanoparticle design principles, imaging modalities and instrumentations, and common targets for atherosclerosis. The review is concluded and highlighted with discussions on challenges and opportunities for bringing nanoparticles into in vivo (pre)clinical intravascular applications.
动脉粥样硬化是发病率和死亡率的主要原因,高危动脉粥样硬化斑块可导致心肌梗死、中风和/或猝死。已经开发了各种成像和传感技术(例如超声、光学相干断层扫描、荧光、光声)来扫描血管内部,以提供对高危动脉粥样硬化斑块的准确检测。纳米颗粒已被用于血管内成像,以实现高危斑块的靶向检测、增强图像对比度,并且在某些应用中还提供动脉粥样硬化的治疗功能。本文综述了用于动脉粥样硬化血管内成像的纳米颗粒的最新进展。我们讨论了基本的纳米颗粒设计原则、成像方式和仪器以及动脉粥样硬化的常见靶点。本文以讨论将纳米颗粒引入体内(临床前)血管内应用的挑战和机遇为结尾并进行了强调。